System X /GSH/GPX4 : An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy.

Front Pharmacol

School of Pharmacy, University of South China, Phase I Clinical Trial Centre, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.

Published: August 2022

The activation of ferroptosis is a new effective way to treat drug-resistant solid tumors. Ferroptosis is an iron-mediated form of cell death caused by the accumulation of lipid peroxides. The intracellular imbalance between oxidant and antioxidant due to the abnormal expression of multiple redox active enzymes will promote the produce of reactive oxygen species (ROS). So far, a few pathways and regulators have been discovered to regulate ferroptosis. In particular, the cystine/glutamate antiporter (System X ), glutathione peroxidase 4 (GPX4) and glutathione (GSH) (System X /GSH/GPX4 axis) plays a key role in preventing lipid peroxidation-mediated ferroptosis, because of which could be inhibited by blocking System X /GSH/GPX4 axis. This review aims to present the current understanding of the mechanism of ferroptosis based on the System X /GSH/GPX4 axis in the treatment of drug-resistant solid tumors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465090PMC
http://dx.doi.org/10.3389/fphar.2022.910292DOI Listing

Publication Analysis

Top Keywords

system /gsh/gpx4
16
drug-resistant solid
12
/gsh/gpx4 axis
12
solid tumors
8
system
6
ferroptosis
6
/gsh/gpx4 antioxidant
4
antioxidant system
4
system ferroptosis
4
ferroptosis drug-resistant
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!